BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27931797)

  • 1. ERBB2 Is Essential for the Growth of Chemically Induced Skin Tumors in Mice.
    Dahlhoff M; Muzumdar S; Schäfer M; Schneider MR
    J Invest Dermatol; 2017 Apr; 137(4):921-930. PubMed ID: 27931797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis.
    Dahlhoff M; Schäfer M; Muzumdar S; Rose C; Schneider MR
    Mol Oncol; 2015 Nov; 9(9):1825-33. PubMed ID: 26194695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis.
    Passeri D; Doldo E; Tarquini C; Costanza G; Mazzaglia D; Agostinelli S; Campione E; Di Stefani A; Giunta A; Bianchi L; Orlandi A
    J Invest Dermatol; 2016 Jun; 136(6):1255-1266. PubMed ID: 26945879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased incidence of papillomas in mice with impaired EGFR function during multi-stage skin carcinogenesis.
    Dahlhoff M; Rose C; Wolf E; Schneider MR
    Exp Dermatol; 2011 Mar; 20(3):290-3. PubMed ID: 21323750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of 14-3-3σ sensitizes mice to DMBA/TPA-induced papillomatosis.
    Winter M; Lodygin D; Verdoodt B; Hermeking H
    Oncotarget; 2016 Jul; 7(30):46862-46870. PubMed ID: 27409835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway.
    Bajpai D; Mehdizadeh S; Uchiyama A; Inoue Y; Sawaya A; Overmiller A; Brooks SR; Hasneen K; Kellett M; Palazzo E; Motegi SI; Yuspa SH; Cataisson C; Morasso MI
    Oncogene; 2021 May; 40(21):3680-3694. PubMed ID: 33947961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
    Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
    Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
    Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
    Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis.
    Sterneck E; Zhu S; Ramirez A; Jorcano JL; Smart RC
    Oncogene; 2006 Feb; 25(8):1272-1276. PubMed ID: 16205634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis.
    Antsiferova M; Martin C; Huber M; Feyerabend TB; Förster A; Hartmann K; Rodewald HR; Hohl D; Werner S
    J Immunol; 2013 Dec; 191(12):6147-55. PubMed ID: 24227781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional disruption of rictor demonstrates a direct requirement for mTORC2 in skin tumor development and continued growth of established tumors.
    Carr TD; Feehan RP; Hall MN; Rüegg MA; Shantz LM
    Carcinogenesis; 2015 Apr; 36(4):487-97. PubMed ID: 25740823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of retrotransposition of long interspersed nucleotide element-1 in skin tumorigenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate.
    Okudaira N; Goto M; Yanobu-Takanashi R; Tamura M; An A; Abe Y; Kano S; Hagiwara S; Ishizaka Y; Okamura T
    Cancer Sci; 2011 Nov; 102(11):2000-6. PubMed ID: 21827582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of both the epidermal growth factor receptor and erbB2 effectively inhibits the promotion of skin tumors during two-stage carcinogenesis.
    Kiguchi K; Kitamura T; Moore T; Rumi M; Chang HC; Treece D; Ruffino L; Connolly K; DiGiovanni J
    Cancer Prev Res (Phila); 2010 Aug; 3(8):940-52. PubMed ID: 20682802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
    He G; Muga S; Thuillier P; Lubet RA; Fischer SM
    Mol Carcinog; 2005 Aug; 43(4):198-206. PubMed ID: 15864802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.
    Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD
    Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CENP-R acts bilaterally as a tumor suppressor and as an oncogene in the two-stage skin carcinogenesis model.
    Okumura K; Kagawa N; Saito M; Yoshizawa Y; Munakata H; Isogai E; Fukagawa T; Wakabayashi Y
    Cancer Sci; 2017 Nov; 108(11):2142-2148. PubMed ID: 28795467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.